Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang(Weifang People's Hospital), Xichen Lin(GlaxoSmithKline (China)), Yafei Huang(University of Denver), Yan Xu(Shanghai First People's Hospital), Qianqian Wu(GlaxoSmithKline (China)), Yaobang Cheng(GlaxoSmithKline (China)), Qinghua Meng(GlaxoSmithKline (China)), Ziqiang Cheng(Shandong Agricultural University), Qian Liu(Wuhan University), Wei Cai(GlaxoSmithKline (China)), Ling Zhou(China Pharmaceutical University), Fangbin Han(GlaxoSmithKline (China)), Feng Ren(Henan Medical University), Guifeng Zhang(GlaxoSmithKline (China)), John D. Elliott(GlaxoSmithKline (China)), Stewart Leung(GlaxoSmithKline (China)), Zhijun Xiang(GlaxoSmithKline (China)), Sijie Lu(GlaxoSmithKline (China)), Jia‐Ning Xiang(GlaxoSmithKline (China)), Ting Yang(GlaxoSmithKline (China)), Yonggang Zhao(GlaxoSmithKline (China))
Cited by 76
Related Papers
The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study
|The Lancet Global Health|2020|1.6k
Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals
|ACS Nano|2015|404
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
|Journal of Chemical Information and Modeling|2023|196